Table: Modalis Therapeutics -2022 group results

Modalis Therapeutics

13/02/2023 06:00

Feb 13 (Reuters)- 
          Modalis Therapeutics Corporation 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2022    Dec 31, 2021   Dec 31, 2023     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          40 mln           1 mln                                
                               (-99.7 pct)                             
  Operating     loss 2.06       loss 1.24                              
  Recurring     loss 2.00       loss 1.23                              
  Net
  Net           loss 2.70     loss 738 mln                             
  EPS        loss 92.85 yen  loss 25.70 yen                            
  Ann Div          NIL             NIL            NIL                  
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - Modalis Therapeutics Corporation.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T